MARINUS PHARMACEUTICALS, INC. Quarterly Net Income (Loss) Attributable to Parent in USD from Q1 2013 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
Summary
Marinus Pharmaceuticals, Inc. quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from Q1 2013 to Q2 2024.
  • Marinus Pharmaceuticals, Inc. Net Income (Loss) Attributable to Parent for the quarter ending June 30, 2024 was -$35.8M, a 12.2% decline year-over-year.
  • Marinus Pharmaceuticals, Inc. Net Income (Loss) Attributable to Parent for the twelve months ending June 30, 2024 was -$149M, a 439% decline year-over-year.
  • Marinus Pharmaceuticals, Inc. annual Net Income (Loss) Attributable to Parent for 2023 was -$141M, a 614% decline from 2022.
  • Marinus Pharmaceuticals, Inc. annual Net Income (Loss) Attributable to Parent for 2022 was -$19.8M, a 79.9% increase from 2021.
  • Marinus Pharmaceuticals, Inc. annual Net Income (Loss) Attributable to Parent for 2021 was -$98.8M, a 46.4% decline from 2020.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Quarterly (USD)
Net Income (Loss) Attributable to Parent, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2024 -$149M -$35.8M -$3.89M -12.2% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-13
Q1 2024 -$145M -$38.7M -$3.94M -11.3% Jan 1, 2024 Mar 31, 2024 10-Q 2024-08-13
Q4 2023 -$141M -$41.8M -$7.46M -21.7% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-05
Q3 2023 -$134M -$33M -$106M -145% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-07
Q2 2023 -$27.7M -$31.9M +$7.5M +19% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-13
Q1 2023 -$35.2M -$34.7M -$15.4M -79.4% Jan 1, 2023 Mar 31, 2023 10-Q 2024-08-13
Q4 2022 -$19.8M -$34.3M -$6.01M -21.2% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-05
Q3 2022 -$13.8M $73.3M +$92.8M Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-07
Q2 2022 -$107M -$39.4M -$15.6M -65.5% Apr 1, 2022 Jun 30, 2022 10-Q 2023-11-07
Q1 2022 -$91M -$19.4M +$7.78M +28.7% Jan 1, 2022 Mar 31, 2022 10-Q 2023-11-07
Q4 2021 -$98.8M -$28.3M -$10.8M -62% Oct 1, 2021 Dec 31, 2021 10-K 2023-03-09
Q3 2021 -$87.9M -$19.5M -$3.85M -24.6% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-07
Q2 2021 -$84.1M -$23.8M -$8.15M -52% Apr 1, 2021 Jun 30, 2021 10-Q 2022-11-07
Q1 2021 -$75.9M -$27.1M -$8.47M -45.4% Jan 1, 2021 Mar 31, 2021 10-Q 2022-11-07
Q4 2020 -$67.5M -$17.5M -$2.06M -13.4% Oct 1, 2020 Dec 31, 2020 10-K 2022-03-24
Q3 2020 -$65.4M -$15.7M -$1.85M -13.4% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-09
Q2 2020 -$63.6M -$15.7M -$3.25M -26.2% Apr 1, 2020 Jun 30, 2020 10-Q 2021-11-09
Q1 2020 -$60.3M -$18.7M -$6.19M -49.6% Jan 1, 2020 Mar 31, 2020 10-Q 2021-11-09
Q4 2019 -$54.1M -$15.4M -$5.3M -52.4% Oct 1, 2019 Dec 31, 2019 10-K 2020-03-16
Q3 2019 -$48.8M -$13.8M -$2.7M -24.3% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-09
Q2 2019 -$46.1M -$12.4M -$2.92M -30.7% Apr 1, 2019 Jun 30, 2019 10-Q 2020-11-09
Q1 2019 -$43.2M -$12.5M -$6.48M -108% Jan 1, 2019 Mar 31, 2019 10-Q 2020-11-09
Q4 2018 -$36.7M -$10.1M -$5.38M -113% Oct 1, 2018 Dec 31, 2018 10-K 2020-03-16
Q3 2018 -$31.4M -$11.1M -$6.94M -166% Jul 1, 2018 Sep 30, 2018 10-K 2020-03-16
Q2 2018 -$24.4M -$9.5M -$4.95M -109% Apr 1, 2018 Jun 30, 2018 10-K 2020-03-16
Q1 2018 -$19.5M -$6M -$561K -10.3% Jan 1, 2018 Mar 31, 2018 10-K 2020-03-16
Q4 2017 -$18.9M -$4.74M +$1.28M +21.2% Oct 1, 2017 Dec 31, 2017 10-K 2019-03-12
Q3 2017 -$20.2M -$4.17M +$2.29M +35.5% Jul 1, 2017 Sep 30, 2017 10-K 2019-03-12
Q2 2017 -$22.5M -$4.55M +$4.4M +49.1% Apr 1, 2017 Jun 30, 2017 10-K 2019-03-12
Q1 2017 -$26.9M -$5.44M +$1.78M +24.6% Jan 1, 2017 Mar 31, 2017 10-K 2019-03-12
Q4 2016 -$28.6M -$6.01M +$1.59M +20.9% Oct 1, 2016 Dec 31, 2016 10-K 2018-03-07
Q3 2016 -$30.2M -$6.46M -$1.5M -30.2% Jul 1, 2016 Sep 30, 2016 10-K 2018-03-07
Q2 2016 -$28.7M -$8.95M -$3.68M -69.7% Apr 1, 2016 Jun 30, 2016 10-K 2018-03-07
Q1 2016 -$25.1M -$7.22M -$209K -2.98% Jan 1, 2016 Mar 31, 2016 10-K 2018-03-07
Q4 2015 -$24.9M -$7.61M -$4M -111% Oct 1, 2015 Dec 31, 2015 10-K 2018-03-07
Q3 2015 -$20.9M -$4.96M -$3.3M -198% Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-08
Q2 2015 -$17.6M -$5.27M -$1.95M -58.7% Apr 1, 2015 Jun 30, 2015 10-Q 2016-08-09
Q1 2015 -$15.6M -$7.01M -$4.77M -214% Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-02
Q4 2014 -$10.8M -$3.61M -$2.21M -159% Oct 1, 2014 Dec 31, 2014 10-K 2016-03-07
Q3 2014 -$8.62M -$1.67M -$444K -36.3% Jul 1, 2014 Sep 30, 2014 10-K 2016-03-07
Q2 2014 -$8.18M -$3.32M -$1.64M -97.6% Apr 1, 2014 Jun 30, 2014 10-K 2016-03-07
Q1 2014 -$6.54M -$2.24M -$1.27M -130% Jan 1, 2014 Mar 31, 2014 10-K 2016-03-07
Q4 2013 -$5.27M -$1.39M Oct 1, 2013 Dec 31, 2013 10-K 2015-03-12
Q3 2013 -$1.22M Jul 1, 2013 Sep 30, 2013 10-K 2015-03-12
Q2 2013 -$1.68M Apr 1, 2013 Jun 30, 2013 10-K 2015-03-12
Q1 2013 -$970K Jan 1, 2013 Mar 31, 2013 10-K 2015-03-12
* An asterisk sign (*) next to the value indicates that the value is likely invalid.